These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 10668476

  • 1. Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy.
    Gougeon ML, Montagnier L.
    Ann N Y Acad Sci; 1999; 887():199-212. PubMed ID: 10668476
    [Abstract] [Full Text] [Related]

  • 2. HIV, cytokines and programmed cell death. A subtle interplay.
    Gougeon ML, Ledru E, Naora H, Bocchino M, Lecoeur H.
    Ann N Y Acad Sci; 2000; 926():30-45. PubMed ID: 11193039
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics?
    Bucy RP, Kilby JM.
    AIDS; 2001 Feb; 15 Suppl 2():S36-42. PubMed ID: 11424975
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.
    Estaquier J, Idziorek T, de Bels F, Barré-Sinoussi F, Hurtrel B, Aubertin AM, Venet A, Mehtali M, Muchmore E, Michel P, Mouton Y, Girard M, Ameisen JC.
    Proc Natl Acad Sci U S A; 1994 Sep 27; 91(20):9431-5. PubMed ID: 7937784
    [Abstract] [Full Text] [Related]

  • 9. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T, Qiu Z, Wang A, Sheng R.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 25; 82(20):1391-5. PubMed ID: 12509921
    [Abstract] [Full Text] [Related]

  • 10. Using death to one's advantage: HIV modulation of apoptosis.
    Ross TM.
    Leukemia; 2001 Mar 25; 15(3):332-41. PubMed ID: 11237054
    [Abstract] [Full Text] [Related]

  • 11. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
    D'Amico R, Yang Y, Mildvan D, Evans SR, Schnizlein-Bick CT, Hafner R, Webb N, Basar M, Zackin R, Jacobson MA.
    J Clin Immunol; 2005 Mar 25; 25(2):106-15. PubMed ID: 15821887
    [Abstract] [Full Text] [Related]

  • 12. Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
    Price DA, Scullard G, Oxenius A, Braganza R, Beddows SA, Kazmi S, Clarke JR, Johnson GE, Weber JN, Phillips RE.
    J Virol; 2003 May 25; 77(10):6041-9. PubMed ID: 12719595
    [Abstract] [Full Text] [Related]

  • 13. Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.
    Holm GH, Gabuzda D.
    J Virol; 2005 May 25; 79(10):6299-311. PubMed ID: 15858014
    [Abstract] [Full Text] [Related]

  • 14. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E, Al Tabaa Y, Baillat V, Segondy M, Picot MC, Reynes J, Vendrell JP.
    Cytometry B Clin Cytom; 2009 Jul 25; 76(4):249-60. PubMed ID: 19072838
    [Abstract] [Full Text] [Related]

  • 15. CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients.
    Franco JM, León-Leal JA, Leal M, Cano-Rodriguez A, Pineda JA, Macías J, Rubio A, Rey C, Sanchez B, Lissen E.
    Clin Exp Immunol; 2000 Mar 25; 119(3):493-8. PubMed ID: 10691922
    [Abstract] [Full Text] [Related]

  • 16. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G, Ceccarelli G, Serafino S, Giustini N, Cavallari EN, Bianchi L, Pavone P, Bellelli V, Turriziani O, Antonelli G, Stroffolini T, Vullo V.
    J Med Virol; 2016 Aug 25; 88(8):1347-56. PubMed ID: 26765625
    [Abstract] [Full Text] [Related]

  • 17. HIV-1 and immune control: can we change the course of HIV-1?
    Kovacs A, Connors M.
    Lancet; 2004 Mar 13; 363(9412):833-4. PubMed ID: 15031022
    [No Abstract] [Full Text] [Related]

  • 18. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
    Qiu ZF, Li TS, Ruan GR, Han Y, Xie J, Zuo LY, Li YL, Wang AX.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun 13; 28(3):386-90. PubMed ID: 16900640
    [Abstract] [Full Text] [Related]

  • 19. Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis.
    Johnson N, Parkin JM.
    Clin Exp Immunol; 1998 Aug 13; 113(2):229-34. PubMed ID: 9717972
    [Abstract] [Full Text] [Related]

  • 20. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
    Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, Dandekar S.
    J Virol; 2003 Nov 13; 77(21):11708-17. PubMed ID: 14557656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.